Trial Profile
Observational Study of Apremilast Use and Effectiveness Over a One Year Treatment Period in Patients With Psoriasis in The Netherlands
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms APRIL
- Sponsors Amgen; Celgene Corporation
- 14 Jul 2020 Status changed from active, no longer recruiting to completed.
- 02 Mar 2020 Planned End Date changed from 31 Dec 2018 to 30 Jun 2020.
- 02 Mar 2020 Status changed from recruiting to active, no longer recruiting.